Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04634461 · ClinicalTrials.gov registry record
The Relationship Between Panic Attack Symptoms and Atrial Fibrillation Episodes.
A clinical trial, sponsored by State University of New York at Buffalo.
- Terminated
- Registry status
- 13
- Enrollment target
NCT04634461: Clinical Trial study, sponsored by State University of New York at Buffalo.
NCT04634461 is a clinical trial that was terminated before completion, run by State University of New York at Buffalo. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04634461 was terminated before completion, sponsored by State University of New York at Buffalo.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
To characterize the relationship between panic attack symptoms and atrial fibrillation episodes using a real-time assessment data capturing system that reduces recall biases of previous research.
Primary Outcome
Self reporting of atrial fibrillation symptoms
Interventions
- DEVICE Cardiac Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2025-04-07 |
Why NCT04634461 stopped before completion
NCT04634461 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Monitor is the first listed.
NCT04634461 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04634461 about?
NCT04634461 is a clinical study titled "The Relationship Between Panic Attack Symptoms and Atrial Fibrillation Episodes.". To characterize the relationship between panic attack symptoms and atrial fibrillation episodes using a real-time assessment data capturing system that reduces recall biases of previous research.
What is the current status of trial NCT04634461?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2021-03-15. Estimated completion is 2025-04-07.
What interventions are being tested in trial NCT04634461?
The interventions under investigation include: Cardiac Monitor (DEVICE).
Who is sponsoring clinical trial NCT04634461?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI